Search Results
| No. |
VISDB ID▲▼ |
Virus Name▲▼ |
Subtype▲▼ |
Virus Genome▲▼ |
Breakpoint 1▲▼ |
Breakpoint 2▲▼ |
Human Genome▲▼ |
Chr▲▼ |
Start▲▼ |
End▲▼ |
Loci▲▼ |
Target Gene▲▼ |
Sample Type▲▼ |
Disease▲▼ |
Method▲▼ |
PubMed ID▲▼ |
Year▲▼ |
Curated Way▲▼ |
| 7621 |
TVIS20024483
|
Human Papillomavirus |
HPV16 |
K02718 |
7608 |
- |
hg38 |
chr2 |
200073041 |
200073041 |
q33.1 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 7622 |
TVIS20024484
|
Human Papillomavirus |
HPV16 |
K02718 |
6851 |
- |
hg38 |
chr2 |
200107702 |
200107702 |
q33.1 |
ENSG00000287027, ENSG00000294361 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 7623 |
TVIS20024485
|
Human Papillomavirus |
HPV16 |
K02718 |
4301 |
- |
hg38 |
chrX |
75700706 |
75700706 |
q13.3 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 7624 |
TVIS20024486
|
Human Papillomavirus |
HPV16 |
K02718 |
939 |
- |
hg38 |
chr1 |
62309541 |
62309541 |
p31.3 |
KANK4 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 7625 |
TVIS20024487
|
Human Papillomavirus |
HPV16 |
K02718 |
4301 |
- |
hg38 |
chr12 |
60707231 |
60707231 |
q14.1 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 7626 |
TVIS20024488
|
Human Papillomavirus |
HPV16 |
K02718 |
7307 |
- |
hg38 |
chr15 |
39068581 |
39068581 |
q14 |
ENSG00000259345, LINC02694 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 7627 |
TVIS20024489
|
Human Papillomavirus |
HPV16 |
K02718 |
6020 |
- |
hg38 |
chr15 |
39143519 |
39143519 |
q14 |
ENSG00000259345, LINC02694 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 7628 |
TVIS20024490
|
Human Papillomavirus |
HPV16 |
K02718 |
1311 |
- |
hg38 |
chr9 |
105568565 |
105568565 |
q31.2 |
FKTN |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 7629 |
TVIS20024491
|
Human Papillomavirus |
HPV16 |
K02718 |
5908 |
- |
hg38 |
chr15 |
39154655 |
39154655 |
q14 |
ENSG00000259345, LINC02694 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 7630 |
TVIS20024492
|
Human Papillomavirus |
HPV16 |
K02718 |
3228 |
- |
hg38 |
chr2 |
200102511 |
200102511 |
q33.1 |
ENSG00000287027, ENSG00000294361 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |